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Childrenn overview of recent ﬁndings from the Northern California Childhood Leukemia
Study (NCCLS) on factors related to the immune system including child's vaccination history and measures of
child's exposure to infectious agents, namely daycare attendance, infection during infancy, and parental
social contact in the work place. We also provide suggestions for the next stages of studies.
© 2008 Elsevier Inc. Open access under CC BY-NC-ND license.ContentsFindings from the Northern California childhood leukemia study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
Study design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
Daycare attendance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
Infection during infancy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
Vaccination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
Parental social contact in the work place . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
Looking into the future . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
Acknowledgment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120Multiple lines of evidence support a role for infections in the
etiology of childhood acute lymphoblastic leukemia (ALL), and there are
two prominent hypotheses concerning the underlying mechanisms.
Greaves hypothesized that delayed exposure to common infections
leads to an increased risk of childhood leukemia, especially common
pre-B ALL (cALL), which has a peak incidence in 2–5 year olds [1,2].
Greaves proposed that a minimum of two separate genetic events may
be responsible for the development of cALL. The ﬁrst event occurs
spontaneously in utero during the expansion of B-cell precursors to
establish a preleukemic clone; the second event occurs in the same
mutated preleukemic clone following antigenic challenge early in life.
Children who have a delayed exposure to common infectious agents
develop a less well modulated immune system and may experienceNC-ND license.greater cell proliferation following common infections, and therefore,
have an increased risk of the second mutation leading to the
development of ALL [1,2]. A related hypothesis by Kinlen suggests
that childhood leukemiamight result from a rare response to a common
but unidentiﬁed infection and that increased risks would occur when
populations were mixed so that infected and susceptible individuals
had an increased level of contact [3]. He later hypothesized that
childhood leukemia is caused by a viral infection(s), the transmission of
which is promoted by population mixing [4]. Both of these hypotheses
are consistent with the proposition that leukemia may be caused by
abnormal immune response to infections. The Greaves hypothesis
emphasizes the importance of the timing of exposure and does not
focus on speciﬁc agents, while the Kinlen hypothesis appears to favor
speciﬁc agents (although not yet identiﬁed).
Directly testing the hypotheses is challenging, because exposure and
response to infections is difﬁcult to quantify and no leukemogenic agent
has been discovered so far. Speciﬁc agents have been assessed in ALL
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but no speciﬁc viral sequences were discovered among leukemia cases
[42]. History of infections using serological methods has also been
assessed, but as summarized by Ross et al., such studies of leukemia
patients were mostly cross-sectional and unable to establish the
temporal relationship between infection and leukemia incidence [5].
Timing is critical, as early infections are likely to positivelymodulate the
immune system thereby reducing risk of leukemia, whereas later
infections in children whose immune system was less well modulated
may increase such risk [6]. Assessing timing via serology has been
attempted with some circumstantial evidence supporting the Greaves
hypothesis [7]; however samples taken after diagnosis may be affected
by the disease, and will reﬂect infections at variable times in the past.
Trying to assess history of infection through interview can also be
problematic due to potential recall bias andmisclassiﬁcation of children
who had asymptomatic infections [5]. Obtaining history of infection
frommedical records reduces thepotential for recall bias, but it still does
not capture asymptomatic infections. In addition, it is not uncommon for
parents to care for children with minor infections without seeking help
from medical professionals; relying solely on medical records will
undoubtedly result in misclassiﬁcation. Under these circumstances,
using surrogate measures or markers of infection can be a good
alternative in etiologic studies of childhood ALL.
Findings from the Northern California childhood leukemia study
Study design
The NCCLS is an ongoing study which commenced in 1995. The
study area includes 35 counties in Northern and Central California. In
the NCCLS, incident cases of newly diagnosed childhood leukemia
(age 0–14 years) are rapidly ascertained from major pediatric clinical
centers in the study area, usually within 72 h after diagnosis. Although
case ascertainment is hospital-based, a comparison with all popula-
tion-based cases recorded by the statewide California Cancer Registry
(2000) conﬁrms that the NCCLS protocol successfully identiﬁed 95% of
all age-eligible newly diagnosed childhood leukemia cases among
residents of the 5-county San Francisco metropolitan area and 76% of
such cases in the other 30 counties. Medical records of all cases are
abstracted and reviewed expeditiously by an expert hematologist to
conﬁrm diagnosis and subtype classiﬁcation. Controls are randomly
selected from the statewide birth certiﬁcate ﬁles maintained by the
Center for Health Statistics in the California Department of Public
Health and individually matched to cases on date of birth, sex,
mother's race (white, African-American, or other), and Hispanic status
(a child is considered Hispanic if either parent is Hispanic). Due to the
unique demographic composition of the study area, approximately
42% of the cases enrolled in the NCCLS are Hispanic. The control to
case ratio was 1:1 for cases diagnosed before December 1999 and 2:1
for those diagnosed afterwards. A detailed protocol for control
selection has been reported elsewhere [8]. A personal interview
with the primary care taker of each case or control subject, usually the
biological mother, was scheduled as soon as consent was obtained. In
addition, written immunization records were obtained directly from
the parents or primary care providers for each subject.
Approximately 1000 cases and 1300 controls are expected to be
enrolled by March 2009, making the NCCLS one of the largest case-
control studies of childhood leukemia to date. Evaluating the role of
immunologic factors is one of the main aims of the study, which has
published a number of ﬁndings related to daycare attendance, infection
during infancy, vaccination, and paternal social contact in thework place.
Daycare attendance
The incidence of childhood leukemia, especially common ALL, is
markedly higher in developed countries than in developing countries[9]. In developed countries, most exposure to common childhood
infections results from contact with other children, and daycare
attendance has been utilized as an indirect measure of early exposure
to infectious agents [10]. Epidemiologic studies have measured
daycare attendance in different ways, such as binary characterization
of attendance (i.e. ever vs. never), age ﬁrst started daycare, and total
duration of daycare attendance. In the NCCLS, we not only evaluated
individual variables that reﬂect different aspects of daycare atten-
dance, but also came upwith a summarymeasure termed “child-hours
of exposure”, which effectively captured the variance contributed by
individual daycare variables [11]. In our analysis of the NCCLS data,
daycare attendance measured by child-hours was associated with a
signiﬁcantly reduced risk of ALL among non-Hispanic white children.
Comparedwith childrenwhodid not attend anydaycare, the odds ratio
(OR) for those who had more than ﬁve thousand child-hours during
infancy was 0.42 [95% conﬁdence interval (CI) 0.18–0.99] for ALL and
0.33 for c-ALL (95% CI: 0.11–1.01), reﬂecting reduced risks of 58% and
67%, respectively. Tests for trendwere also signiﬁcant, thus supporting
a dose–response relationship. The magnitude of the effect associated
with the same number of child-hours was stronger for daycare
attendance during infancy than for daycare attendance anytime
between birth and diagnosis, suggesting that exposure to infectious
agents during infancy offers more protection than later exposure [12].
Intriguingly, daycare attendance was not associated with the risk of
leukemia or ALL among Hispanic children. Compared with non-
Hispanic white children included in the NCCLS, Hispanic children in
the study were of higher birth order, lived with more other children
before ﬁrst grade, and were less likely to start daycare before age one.
Therefore, contact with other children in a daycare setting might not
have been an important source of exposure to infectious agents for the
Hispanic children included in this study.
Given that a number of other studies have also addressed the
relationship between daycare attendance and childhood ALL, we
recently conducted a meta-analysis to appraise the overall evidence to
date. The 14 relevant studies that we identiﬁed [6,12–24] generated a
statistically signiﬁcant summary odds ratio of 0.77 (95% CI 0.66–0.88)
for daycare attended either before age one or two, or between birth to
diagnosis (measured as ever/never in most studies) with a total of
greater than 6000 leukemia cases, most of which were ALL (un-
published ﬁnding, manuscript under preparation). Summary results
for nine studies of daycare attendance speciﬁcally before the age of 1
or 2 years showed a similarly reduced risk. Taken together, the current
body of literature suggests that exposure to infectious agents early in
life through daycare attendance or other social contacts is signiﬁcantly
protective against childhood ALL.
Infection during infancy
In the NCCLS, respondents were asked speciﬁcally whether the
index child experienced any severe diarrhea/vomiting, ear infection,
persistent cough, mouth infection, eye infection, and inﬂuenza during
infancy, and if yes, when the infection occurred, how long it lasted, and
whether it required contacting a doctor and obtaining a prescription.
Our recent analysis showed that self-reported ear infection during
infancy was associated with a signiﬁcantly reduced risk of c-ALL
(OR= 0.32, 95% CI: 0.14–0.74) in non-Hispanic white children [12].
A few other studies have also evaluated the possible role of
infections during infancy in the etiology of ALL, with some showing a
protective effect [16,25] and others suggesting the opposite [26]. As
discussed earlier, it seems straightforward to directly obtain history of
infections through interview and/or medical record abstraction. In
reality, however, such a practice faces a number of methodological
challenges. Paradoxically, surrogate measures or indicators of the
potential of infections such as daycare attendance may be a good or
even better measure to use in epidemiologic studies to evaluate the
etiology of childhood ALL.
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In the NCCLS, we made a special effort to obtain histories of
childhood vaccinations exclusively through written immunization
records kept by the parents and/or primary care physicians, whichwas
a major improvement over many previous studies that relied on
parental recall for exposure assessment. In addition to recording
whether a subject had or had not received a speciﬁc vaccination, we
collected data regarding number of doses, as well as date of each
vaccination. These detailed data were useful for a more accurate and
informative analysis. The NCCLS data showed that vaccinations against
diphtheria, pertussis, tetanus, poliomyelitis, measles, mumps, and
rubellawerenot associatedwith the risk of childhoodALL. On the other
hand, Haemophilus inﬂuenzae type b (Hib) vaccination was associated
with a signiﬁcantly reduced risk of childhood ALL. The OR associated
with each dose of Hib vaccine was 0.81 (95% CI: 0.66–0.98) [27].
Studies evaluating the relationship between vaccination and
childhood leukemia were summarized in 2005 [27]. By that time,
nine studies had reported a protective effect of certain types of
vaccination, two studies had suggested the opposite, and three studies
had found no association [27]. Additional studies have been published
more recently and reported no association [28,29]. Vaccination
practice in a given country is highly inﬂuenced by policies and
recommendations made by health authorities that are usually
afﬁliated with the government. If adherence to those recommenda-
tions is good, one would expect very little, if any, variation in
vaccination coverage among individuals in the general population. As
a result, investigators would be less likely to observe any association
between vaccination and childhood leukemia, even if such an
association truly exists. The timing of the NCCLS coincides with the
window of opportunity to study the potential etiologic role of Hib
vaccination. In the US, Hib vaccine has been administered on a large
scale for more than 15 years. Future studies in the US may have
difﬁculty assessing the role of Hib vaccine in the etiology of childhood
ALL since most children will have received this vaccine following the
recommended vaccination schedule at that time.
Parental social contact in the work place
Parental social contact in the work place is another proxy measure
for a child's risk of infection that has been used to study the infectious
etiology of childhood leukemia. Seven published studies other than
NCCLS have examined parental social contact at work and childhood
leukemia risk, and have produced inconsistent results [22,30–35]. Four
of the seven studies found a positive association between higher
parental occupational social contact and childhood leukemia risk
especially for children living in the rural areas [30–33], while three
other studies found no association. Several factors may have
contributed to the inconsistencies [22,34,35]. Most of the studies did
not assess the role of maternal social contact at work since the
information on maternal occupation was not routinely available in
those studies [30–35]. In addition, all of the studies had information on
father's employment at only one or two points in time: at birth [22,30–
33,35], at the time of child's death [34], or at the time of diagnosis
[22,35]; none of the studies included information on the duration of
the job. It may be important to account for the duration of the parental
occupation since a parent's probability of being in contactwith carriers
of infectious agents may rise with increasing duration of the work.
In the NCCLS, parents were interviewed about history of employ-
ment after child's birth up to the age of three, including the duration of
each job held. An index of occupational social contact months was
created using the level of social contact assigned to each job and the
duration of the occupation. The results showed that increasing levels of
parental social contact in the work place is associated with an
increased risk of childhood ALL only for children living in rural areas
when the duration of the occupation was considered; no signiﬁcantassociations were observed when duration of the parental occupation
was ignored [36].
The NCCLS results suggest that duration of parental occupation
may be an important variable to include when evaluating the
association between parental social contact at work and childhood
leukemia. Since NCCLS is the ﬁrst study to include duration of parental
occupation and the number of subjects living in the rural areas is
small, the results need to be replicated by future studies.
Looking into the future
To date, numerous epidemiologic studies have provided consistent
yet indirect support for the role of infections in the etiology of
childhood ALL. What else can be done to advance our understanding
of this important topic?
Trying to identify speciﬁc agents is certainly one possible direction.
The utility of cross-sectional serologic studies within case-control
studies is questionable, since it is difﬁcult to establish temporal
relationship between infection and leukemia incidence. Analyzing
specimens collected at birth (e.g. cord blood or Guthrie cards routinely
collected for the purpose of genetic screening), maternal blood speci-
mens obtained during pregnancy, or pediatric pre-diagnostic specimens
could be more informative. Given the rarity of childhood leukemia, it is
not feasible to establish a cohort or “biological sample bank” for the
study of this disease. However, efforts are under way to utilize existing
large cohort studies to explore some aspects of leukemogenesis. A group
of large cohorts comprisingoveronemillion subjectswill be followed for
leukemia incidence in coming years, under the direction of the
International Childhood Cancer Cohort Consortium (I4C) [37]. Given
that the initial genetic changes that lead to ALL are muchmore frequent
than the disease diagnosis, these cohort studiesmay be able to examine
what pattern of infections are protective among children born with
mutations that are linked to leukemia. For example,1 in 100 children are
bornwith a leukemia-associated chromosomal translocation, TEL-AML1
[38], a genetic change known to occur in utero in children who develop
leukemia [39]. Only approximately 1 in 8000 children will eventually
develop leukemia with this mutation. Understanding the pattern of
immune modulation, particularly infections and vaccinations among
those TEL-AML1 carriers who remain healthy, will provide important
insight into the modulating role of infections and may help us develop
preventive interventions. Maternal and child samples collected in such
cohorts can be used to screen for patterns of infections, as well as
children's response to infections. Technologic advances in the last few
years havemade it possible to assess a large number of parameters, such
as cytokine proﬁles and speciﬁc antibodies, using microarrays. Addi-
tional resources such as neonatal blood spots and maternal pregnancy
blood specimens, both of which are banked for children born in
California, may also be appropriate for this research.
An intriguing possibility was suggested by a recent report
demonstrating a high prevalence of adenovirus C infection among
newborns who later developed leukemia compared to newborns who
did not develop leukemia [40]. If conﬁrmed, this result is suggestive of
a “hit and run”mechanism, as adenovirus C is not present in pediatric
leukemias [41]. The mechanism by which the adenovirus would
impact leukemogenesis would likely not be related to the immune
modulation (infections early in life) or immune-stimulatory (infec-
tions immediately preceding diagnosis) arguments made above. An
infection in utero during a period of immunologic naivety would not
modulate the immune system but could elicit anti-viral cellular
mechanisms including viral and somatic gene methylation.
Nevertheless, it is important to note that there may not be a
speciﬁc agent or agents that “cause” leukemia. The search for speciﬁc
viruses as transforming agents in leukemia cells has yielded negative
results; and common infections are more promising candidates, with
the pattern of infections more critical than their speciﬁc identities.
Epidemiologic studies have helped pinpoint the potential role of
120 X. Ma et al. / Blood Cells, Molecules, and Diseases 42 (2009) 117–120infection and will continue to help us decipher the etiology of
childhood ALL, as long as we strive to sharpen our tools. First,
improving exposure assessment is critical to enhancing the precision
of epidemiologic studies. Both direct and proxymeasures of infections
need to be assessed in a more focused and detailed way. This includes
an exposure assessment strategy that accounts for the various sources
of a child's potential exposure to infectious agents, both in and outside
the home. Second, it will be important to classify the disease more
precisely. Different subtypes may be etiologically distinct with regard
to the role of infectious agents. Third, additional support for an
immune-related etiology of childhood ALL and speciﬁc clues about
biological mechanisms can be obtained by examining the role of
genetic susceptibility conferred by variation in immune-regulatory
genes, such as those residing in the major histocompatibility complex.
Finally, given the rarity of childhood ALL, the imprecise results
generated by many previous studies, and the need to further
categorize the disease, it will be very helpful to have similar protocols
across individual studies and conduct pooled analyses in the context
of the recently assembled International Childhood Leukemia Con-
sortium (CLIC), a group of 14 epidemiologic studies of childhood
leukemia representing populations from 10 different countries, and
within the I4C cohort consortium mentioned above.
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